CLINICAL_TRIALS
ClinicalTrials.gov record update
Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01932554
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:57.683568+00:00
- Published At
- 2015-03-26T00:00:00+00:00
- Record Updated At
- 2015-03-26
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Sickle Cell Disease", "Hb-SS Disease With Vasoocclusive Pain", "Hemoglobin SS Disease With Vasoocclusive Crisis", "Other Sickle Cell Disease With Vaso-Occlusive Pain", "Hemoglobin SS Disease With Crisis"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-03-26"- protocolSection.identificationModule.nctId
"NCT01932554"- protocolSection.identificationModule.officialTitle
"Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.